Enovis Corp Net Change in Cash
Enovis Corp (ENOV) reported Net Change in Cash of -$23.83 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-06
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-04-03 was -$3.26M.
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-04-04 was -$9.71M, a 132.67% decline year-over-year.
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-29 was $29.71M.
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$2.40M.
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$11.78M, a 453.16% decline from fiscal 2024.
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $3.33M, a 83.76% decline from fiscal 2023.
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $20.54M.
- Enovis Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$695.08M, a 212.42% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-07-03 | -$23.83M 10-Q · filed 2026-08-06 | |||
| 2026-04-03 | -$3.26M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$11.78M 10-K · filed 2026-02-26 | |||
| 2025-10-03 | -$14.55M 10-Q · filed 2025-11-06 | |||
| 2025-07-04 | -$4.09M 10-Q · filed 2026-08-06 | |||
| 2025-04-04 | -$9.71M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $3.33M 10-K · filed 2026-02-26 | |||
| 2024-09-27 | -$5.03M 10-Q · filed 2025-11-06 | |||
| 2024-06-28 | -$1.41M 10-Q · filed 2025-08-07 | |||
| 2024-03-29 | $29.71M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $20.54M 10-K · filed 2026-02-26 | |||
| 2023-09-29 | $7.83M 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $8.20M 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | -$2.40M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$695.08M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$664.41M 10-Q · filed 2023-11-07 | |||
| 2022-07-01 | -$623.76M 10-Q · filed 2023-08-03 | |||
| 2022-04-01 | -$57.87M 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $618.30M 10-K · filed 2024-02-22 | |||
| 2021-10-01 | $76.41M 10-Q · filed 2022-11-02 | |||
| 2021-07-02 | -$38.76M 10-Q · filed 2022-08-04 | |||
| 2021-04-02 | $662.58M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$8.56M 10-K · filed 2023-03-01 | |||
| 2020-10-02 | -$43.21M 10-Q · filed 2021-11-04 | |||
| 2020-07-03 | -$43.24M 10-Q · filed 2021-07-28 | |||
| 2020-04-03 | $255.97M 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | -$135.39M 10-K · filed 2022-02-22 | |||
| 2019-09-27 | -$78.26M 10-Q · filed 2020-10-29 | |||
| 2019-06-28 | -$12.81M 10-Q · filed 2020-08-06 | |||
| 2019-03-29 | -$2.60M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | -$17.00M 10-K · filed 2021-02-18 | |||
| 2017-12-31 | $40.29M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |